What is WP 1066 used for?

WP 1066 is being studied for its potential to treat glioblastoma, which is a type of brain cancer.

Is WP 1066 an approved drug?

No, WP 1066 is currently a research compound in the early phases of clinical testing.

What stage of testing is WP 1066 in?

WP 1066 is currently in Phase 1 and Phase 2 clinical research stages.

What type of drug is WP 1066?

WP 1066 is classified as a small molecule.

Are there known side effects for WP 1066?

There is currently no consumer data available regarding the side effects of WP 1066.

Can I take WP 1066 with other medicines?

Information regarding drug interactions for WP 1066 is not yet available.

WP-1066 | CAS 857064-38-1 | VFUAJMPDXIRPKO

Loading compound...

Small molecule research compound

WP 1066 is a small molecule currently being studied in early-stage research. It is being investigated for its potential use in treating glioblastoma, a type of brain cancer.

How it worksWP 1066 is a small molecule designed to target specific biological processes, though the exact mechanism of action is still being researched in clinical studies.

Used for

glioblastoma

Conditions

glioblastoma

Class

Small moleculeSmall molecule research compound

How to take

This compound is currently in the research phase (Phase 1/2) and is not an FDA-approved medication for general use.

Talk to your doctor

Questions to ask

·Is WP 1066 part of a clinical trial I can join?
·What are the potential risks of WP 1066 for glioblastoma patients?

Educational summary derived from FDA labeling, AI-assisted. Not medical advice — consult a healthcare professional. Updated 2026-04-26.

How to take

Talk to your doctor

Frequently asked questions (6)